Novel β-Lactam/β-Lactamase Combination Versus Meropenem for Treating Nosocomial Pneumonia

This study reports the integrated analysis of two phase III studies of novel β-lactam/β-lactamase combination versus meropenem for treating nosocomial pneumonia (NP) including ventilator-associated pneumonia (VAP). The ASPECT-NP trial compared the efficacy and safety of ceftolozane–tazobactam versus...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wei-Ting, Lai, Chih-Cheng, Cheong, Chong-Un
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963743/
https://www.ncbi.nlm.nih.gov/pubmed/31766123
http://dx.doi.org/10.3390/antibiotics8040219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963743/
https://www.ncbi.nlm.nih.gov/pubmed/31766123
http://dx.doi.org/10.3390/antibiotics8040219

Ejemplares similares